Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease
While ALC may influence microbial diversity, its exact impact on TMAO levels is less well studied than LC [8, 28]
But right now, you need to check every vendor against the latest rules
Choose tirzepatide if: Want maximum weight loss Plateaued on semaglutide Budget allows $100-150/month Willing to try newer medication Read our semaglutide vs tirzepatide comparison for detailed differences
Monitoring blood pressure changes carefully can help prevent serious outcomes and improve overall safety
In recent years, semaglutide has emerged as a breakthrough in the medical community for its ability to help individuals manage their weight more effectively by suppressing appetite